{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:11:13Z","timestamp":1792804273926,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T00:00:00Z","timestamp":1557446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","award":["FP 588\/12"],"award-info":[{"award-number":["FP 588\/12"]}],"id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00204-019-02469-8","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T13:15:38Z","timestamp":1557494138000},"page":"1965-1978","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Functional transepithelial transport measurements to detect nephrotoxicity in vitro using the RPTEC\/TERT1 cell line"],"prefix":"10.1007","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1694-3068","authenticated-orcid":false,"given":"Philipp F.","family":"Secker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadja","family":"Schlichenmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Beilmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Deschl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0416-3811","authenticated-orcid":false,"given":"Daniel R.","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,10]]},"reference":[{"issue":"1 Pt A","key":"2469_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.tiv.2014.12.003","volume":"30","author":"L Aschauer","year":"2015","unstructured":"Aschauer L, Carta G, Vogelsang N, Schlatter E, Jennings P (2015a) Expression of xenobiotic transporters in the human renal proximal tubule cell line RPTEC\/TERT1. Toxicol In Vitro 30(1 Pt A):95\u2013105. \n                    https:\/\/doi.org\/10.1016\/j.tiv.2014.12.003","journal-title":"Toxicol In Vitro"},{"issue":"1","key":"2469_CR2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.tiv.2014.10.005","volume":"30","author":"Lydia Aschauer","year":"2015","unstructured":"Aschauer L, Limonciel A, Wilmes A et al (2015b) Application of RPTEC\/TERT1 cells for investigation of repeat dose nephrotoxicity: a transcriptomic study. Toxicol In Vitro 30(1 Pt A):106\u201316. \n                    https:\/\/doi.org\/10.1016\/j.tiv.2014.10.005","journal-title":"Toxicology in Vitro"},{"issue":"9","key":"2469_CR3","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1039\/b704513a","volume":"132","author":"F Asphahani","year":"2007","unstructured":"Asphahani F, Zhang M (2007) Cellular impedance biosensors for drug screening and toxin detection. Analyst 132(9):835\u2013841. \n                    https:\/\/doi.org\/10.1039\/b704513a","journal-title":"Analyst"},{"issue":"Suppl 2","key":"2469_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1177\/026119290203002S08","volume":"30","author":"T Duff","year":"2002","unstructured":"Duff T, Carter S, Feldman G et al (2002) Transepithelial resistance and inulin permeability as endpoints in in vitro nephrotoxicity testing. Altern Lab Anim 30(Suppl 2):53\u201359","journal-title":"Altern Lab Anim"},{"issue":"9","key":"2469_CR5","doi-asserted-by":"publisher","first-page":"5573","DOI":"10.1128\/AAC.00907-16","volume":"60","author":"Z Gai","year":"2016","unstructured":"Gai Z, Visentin M, Hiller C et al (2016) Organic cation transporter 2 overexpression may confer an increased risk of gentamicin-induced nephrotoxicity. Antimicrob Agents Chemother 60(9):5573\u20135580. \n                    https:\/\/doi.org\/10.1128\/AAC.00907-16","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2469_CR6","doi-asserted-by":"publisher","first-page":"p1","DOI":"10.1159\/000096860","volume":"105","author":"AM Hall","year":"2007","unstructured":"Hall AM, Unwin RJ (2007) The not so 'mighty chondrion': emergence of renal diseases due to mitochondrial dysfunction. Nephron Physiol 105(1):p1\u201310. \n                    https:\/\/doi.org\/10.1159\/000096860","journal-title":"Nephron Physiol"},{"issue":"1","key":"2469_CR7","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1093\/toxsci\/kfu174","volume":"142","author":"V Hausherr","year":"2014","unstructured":"Hausherr V, van Thriel C, Krug A, Leist M, Schobel N (2014) Impairment of glutamate signaling in mouse central nervous system neurons in vitro by tri-ortho-cresyl phosphate at noncytotoxic concentrations. Toxicol Sci 142(1):274\u2013284. \n                    https:\/\/doi.org\/10.1093\/toxsci\/kfu174","journal-title":"Toxicol Sci"},{"issue":"6","key":"2469_CR8","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00424-012-1163-2","volume":"464","author":"SE Jenkinson","year":"2012","unstructured":"Jenkinson SE, Chung GW, van Loon E, Bakar NS, Dalzell AM, Brown CD (2012) The limitations of renal epithelial cell line HK-2 as a model of drug transporter expression and function in the proximal tubule. Pflugers Arch 464(6):601\u2013611. \n                    https:\/\/doi.org\/10.1007\/s00424-012-1163-2","journal-title":"Pflugers Arch"},{"issue":"Suppl 7","key":"2469_CR9","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1002\/jcph.735","volume":"56","author":"EI Lepist","year":"2016","unstructured":"Lepist EI, Ray AS (2016) Renal transporter-mediated drug-drug interactions: are they clinically relevant? J Clin Pharmacol 56(Suppl 7):S73\u201381. \n                    https:\/\/doi.org\/10.1002\/jcph.735","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"2469_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/toxsci\/kfr339","volume":"126","author":"Z Lin","year":"2012","unstructured":"Lin Z, Will Y (2012) Evaluation of drugs with specific organ toxicities in organ-specific cell lines. Toxicol Sci 126(1):114\u2013127. \n                    https:\/\/doi.org\/10.1093\/toxsci\/kfr339","journal-title":"Toxicol Sci"},{"issue":"2","key":"2469_CR11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.0306-5251.2004.2188.x","volume":"59","author":"KK Loboz","year":"2005","unstructured":"Loboz KK, Shenfield GM (2005) Drug combinations and impaired renal function\u2014the 'triple whammy'. Br J Clin Pharmacol 59(2):239\u2013243. \n                    https:\/\/doi.org\/10.1111\/j.0306-5251.2004.2188.x","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"2469_CR12","first-page":"1104","volume":"289","author":"R Masereeuw","year":"1999","unstructured":"Masereeuw R, Moons MM, Toomey BH, Russel FG, Miller DS (1999) Active lucifer yellow secretion in renal proximal tubule: evidence for organic anion transport system crossover. J Pharmacol Exp Ther 289(2):1104\u20131111","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"2469_CR13","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.3390\/toxins2112490","volume":"2","author":"RP Miller","year":"2010","unstructured":"Miller RP, Tadagavadi RK, Ramesh G, Reeves WB (2010) Mechanisms of Cisplatin nephrotoxicity. Toxins (Basel) 2(11):2490\u20132518. \n                    https:\/\/doi.org\/10.3390\/toxins2112490","journal-title":"Toxins (Basel)"},{"key":"2469_CR14","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-pharmtox-011112-140317","volume":"53","author":"KM Morrissey","year":"2013","unstructured":"Morrissey KM, Stocker SL, Wittwer MB, Xu L, Giacomini KM (2013) Renal transporters in drug development. Annu Rev Pharmacol Toxicol 53:503\u2013529. \n                    https:\/\/doi.org\/10.1146\/annurev-pharmtox-011112-140317","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"2469_CR15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2215\/CJN.04800908","volume":"4","author":"M Naesens","year":"2009","unstructured":"Naesens M, Kuypers DR, Sarwal M (2009) Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 4(2):481\u2013508. \n                    https:\/\/doi.org\/10.2215\/CJN.04800908","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"2469_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/his.13064","volume":"70","author":"P Paueksakon","year":"2017","unstructured":"Paueksakon P, Fogo AB (2017) Drug-induced nephropathies. Histopathology 70(1):94\u2013108. \n                    https:\/\/doi.org\/10.1111\/his.13064","journal-title":"Histopathology"},{"key":"2469_CR17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2147\/IJNRD.S39747","volume":"7","author":"GS Pazhayattil","year":"2014","unstructured":"Pazhayattil GS, Shirali AC (2014) Drug-induced impairment of renal function. Int J Nephrol Renovasc Dis 7:457\u2013468. \n                    https:\/\/doi.org\/10.2147\/IJNRD.S39747","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"11","key":"2469_CR18","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1038\/ki.2008.356","volume":"74","author":"MA Perazella","year":"2008","unstructured":"Perazella MA, Markowitz GS (2008) Bisphosphonate nephrotoxicity. Kidney Int 74(11):1385\u20131393. \n                    https:\/\/doi.org\/10.1038\/ki.2008.356","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"2469_CR19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1289\/ehp.98106559","volume":"106","author":"W Pfaller","year":"1998","unstructured":"Pfaller W, Gstraunthaler G (1998) Nephrotoxicity testing in vitro\u2013what we know and what we need to know. Environ Health Perspect 106(Suppl 2):559\u2013569","journal-title":"Environ Health Perspect"},{"issue":"1","key":"2469_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.stem.2014.11.001","volume":"16","author":"S Puri","year":"2015","unstructured":"Puri S, Folias AE, Hebrok M (2015) Plasticity and dedifferentiation within the pancreas: development, homeostasis, and disease. Cell Stem Cell 16(1):18\u201331. \n                    https:\/\/doi.org\/10.1016\/j.stem.2014.11.001","journal-title":"Cell Stem Cell"},{"issue":"2","key":"2469_CR22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/toxsci\/kfq267","volume":"119","author":"Y Quiros","year":"2011","unstructured":"Quiros Y, Vicente-Vicente L, Morales AI, Lopez-Novoa JM, Lopez-Hernandez FJ (2011) An integrative overview on the mechanisms underlying the renal tubular cytotoxicity of gentamicin. Toxicol Sci 119(2):245\u2013256. \n                    https:\/\/doi.org\/10.1093\/toxsci\/kfq267","journal-title":"Toxicol Sci"},{"key":"2469_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.phrs.2016.05.012","volume":"110","author":"C Sauzay","year":"2016","unstructured":"Sauzay C, White-Koning M, Hennebelle I et al (2016) Inhibition of OCT2, MATE1 and MATE2-K as a possible mechanism of drug interaction between pazopanib and cisplatin. Pharmacol Res 110:89\u201395. \n                    https:\/\/doi.org\/10.1016\/j.phrs.2016.05.012","journal-title":"Pharmacol Res"},{"issue":"2","key":"2469_CR24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.14573\/altex.1710181","volume":"35","author":"PF Secker","year":"2018","unstructured":"Secker PF, Luks L, Schlichenmaier N, Dietrich DR (2018) RPTEC\/TERT1 cells form highly differentiated tubules when cultured in a 3D matrix. Altex 35(2):223\u2013234. \n                    https:\/\/doi.org\/10.14573\/altex.1710181","journal-title":"Altex"},{"issue":"11","key":"2469_CR25","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1002\/jps.2600711114","volume":"71","author":"A Selen","year":"1982","unstructured":"Selen A, Amidon GL, Welling PG (1982) Pharmacokinetics of probenecid following oral doses to human volunteers. J Pharm Sci 71(11):1238\u20131242","journal-title":"J Pharm Sci"},{"issue":"9","key":"2469_CR26","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1111\/jphp.12589","volume":"68","author":"MR Sepand","year":"2016","unstructured":"Sepand MR, Ghahremani MH, Razavi-Azarkhiavi K et al (2016) Ellagic acid confers protection against gentamicin-induced oxidative damage, mitochondrial dysfunction and apoptosis-related nephrotoxicity. J Pharm Pharmacol 68(9):1222\u20131232. \n                    https:\/\/doi.org\/10.1111\/jphp.12589","journal-title":"J Pharm Pharmacol"},{"key":"2469_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.taap.2017.02.020","volume":"322","author":"O Sirenko","year":"2017","unstructured":"Sirenko O, Grimm FA, Ryan KR et al (2017) In vitro cardiotoxicity assessment of environmental chemicals using an organotypic human induced pluripotent stem cell-derived model. Toxicol Appl Pharmacol 322:60\u201374. \n                    https:\/\/doi.org\/10.1016\/j.taap.2017.02.020","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"2469_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/2211068214561025","volume":"20","author":"B Srinivasan","year":"2015","unstructured":"Srinivasan B, Kolli AR, Esch MB, Abaci HE, Shuler ML, Hickman JJ (2015) TEER measurement techniques for in vitro barrier model systems. J Lab Autom 20(2):107\u2013126. \n                    https:\/\/doi.org\/10.1177\/2211068214561025","journal-title":"J Lab Autom"},{"issue":"7","key":"2469_CR29","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1021\/mp400720w","volume":"11","author":"HY Tiong","year":"2014","unstructured":"Tiong HY, Huang P, Xiong S, Li Y, Vathsala A, Zink D (2014) Drug-induced nephrotoxicity: clinical impact and preclinical in vitro models. Mol Pharm 11(7):1933\u20131948. \n                    https:\/\/doi.org\/10.1021\/mp400720w","journal-title":"Mol Pharm"},{"issue":"7","key":"2469_CR30","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nrd4609","volume":"14","author":"MJ Waring","year":"2015","unstructured":"Waring MJ, Arrowsmith J, Leach AR et al (2015) An analysis of the attrition of drug candidates from four major pharmaceutical companies. Nat Rev Drug Discov 14(7):475\u2013486. \n                    https:\/\/doi.org\/10.1038\/nrd4609","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"2469_CR31","first-page":"305","volume":"17","author":"MJ Wenting-Van Wijk","year":"1999","unstructured":"Wenting-Van Wijk MJ, Blankenstein MA, Lafeber FP, Bijlsma JW (1999) Relation of plasma dexamethasone to clinical response. Clin Exp Rheumatol 17(3):305\u2013312","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"2469_CR32","doi-asserted-by":"publisher","first-page":"F1365","DOI":"10.1152\/ajprenal.90405.2008","volume":"295","author":"M Wieser","year":"2008","unstructured":"Wieser M, Stadler G, Jennings P et al (2008) hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics. Am J Physiol Renal Physiol 295(5):F1365\u2013F1375. \n                    https:\/\/doi.org\/10.1152\/ajprenal.90405.2008","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"2469_CR33","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00441-009-0882-y","volume":"339","author":"MJ Wilmer","year":"2010","unstructured":"Wilmer MJ, Saleem MA, Masereeuw R et al (2010) Novel conditionally immortalized human proximal tubule cell line expressing functional influx and efflux transporters. Cell Tissue Res 339(2):449\u2013457. \n                    https:\/\/doi.org\/10.1007\/s00441-009-0882-y","journal-title":"Cell Tissue Res"},{"key":"2469_CR34","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jprot.2012.11.022","volume":"79","author":"A Wilmes","year":"2013","unstructured":"Wilmes A, Limonciel A, Aschauer L et al (2013) Application of integrated transcriptomic, proteomic and metabolomic profiling for the delineation of mechanisms of drug induced cell stress. J Proteomics 79:180\u2013194. \n                    https:\/\/doi.org\/10.1016\/j.jprot.2012.11.022","journal-title":"J Proteomics"},{"issue":"2","key":"2469_CR35","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.taap.2014.05.013","volume":"279","author":"A Wilmes","year":"2014","unstructured":"Wilmes A, Aschauer L, Limonciel A, Pfaller W, Jennings P (2014) Evidence for a role of claudin 2 as a proximal tubular stress responsive paracellular water channel. Toxicol Appl Pharmacol 279(2):163\u2013172. \n                    https:\/\/doi.org\/10.1016\/j.taap.2014.05.013","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1 Pt A","key":"2469_CR36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.tiv.2014.10.006","volume":"30","author":"A Wilmes","year":"2015","unstructured":"Wilmes A, Bielow C, Ranninger C, et al. (2015) Mechanism of cisplatin proximal tubule toxicity revealed by integrating transcriptomics, proteomics, metabolomics and biokinetics. Toxicol In Vitro 30(1 Pt A):117\u201327. \n                    https:\/\/doi.org\/10.1016\/j.tiv.2014.10.006","journal-title":"Toxicol In Vitro"},{"issue":"7","key":"2469_CR37","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1369\/0022155412446227","volume":"60","author":"ZK Zsengeller","year":"2012","unstructured":"Zsengeller ZK, Ellezian L, Brown D et al (2012) Cisplatin nephrotoxicity involves mitochondrial i njury with impaired tubular mitochondrial enzyme activity. J Histochem Cytochem 60(7):521\u2013529. \n                    https:\/\/doi.org\/10.1369\/0022155412446227","journal-title":"J Histochem Cytochem"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-019-02469-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-019-02469-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-019-02469-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:08:07Z","timestamp":1588964887000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-019-02469-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,10]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["2469"],"URL":"https:\/\/doi.org\/10.1007\/s00204-019-02469-8","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,10]]},"assertion":[{"value":"28 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}